THEY look like ordinary foals, docile with honey brown coats and white facial patches, content to spend their days munching alfalfa in a cordoned-off pasture in rural Buenos Aires province.

Newly launched ophthalmology company Ollin Biosciences has emerged onto the scene with $100 million in backing and a mission to bring a rival drug for wet age-related macular degeneration (AMD) that ...

The secret to resurrecting these flightless birds that haven't walked the earth for the past four centuries is 'gene-editing ...